Von Willebrand disease 2
MONDO:0013304Type 2 von Willebrand disease (type 2 VWD) is a form of VWD characterized by a bleeding disorder associated with a qualitative deficiency and functional anomalies of the Willebrand factor (von Willebrand factor; VWF).
Also known as: VWD2, von Willebrand disease 2, von Willebrand disease type 2, von Willebrand disease, types 2A, 2B, 2M, and 2N, von Willebrand's disease type 2, von willebrand's disease 2, VON WILLEBRAND disease, type 2, VWD, type 2
18 clinical trials for this condition and its sub-types, 4 tagged with Von Willebrand disease 2 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Von Willebrand disease 2
-
Von Willebrand disease type 2A 2 trials
-
Von Willebrand disease type 2N 2 trials
-
Von Willebrand disease type 2B 1 trial
-
Von Willebrand disease type 2M 1 trial
-
New hope for bleeding disorder: first human trial of HMB-002 begins
Disease control Recruiting nowThis study tests a new medicine, HMB-002, in about 108 adults with von Willebrand disease (types 1 and 2). The goal is to check safety, how the drug moves in the body, and whether it helps control bleeding. It is the first time this drug is being tested in humans, starting with s…
Phase 1/2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug aims to stop bleeding in rare blood disorder
Disease control Recruiting nowThis early-phase study tests a new drug called BT200 in 4-6 adults with type 2B von Willebrand disease who have low platelets and a history of bleeding. The drug is designed to raise von Willebrand factor and platelet levels, which may lower the risk of bleeding. Participants rec…
Phase 2 • Sponsor: Medical University of Vienna • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New study tracks bleeding in von willebrand disease to pave way for better treatments
Knowledge-focused Recruiting nowThis study is for people aged 16 to 70 with von Willebrand disease (VWD), a bleeding disorder. Researchers will collect information on bleeding events, treatments, and quality of life over time. The goal is to understand the real-world impact of VWD and use this data as a baselin…
Sponsor: Hemab ApS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC